Skip to main content

Find Clinical Trials

Home
Conditions
Bone Marrow Diseases

Clinical trial condition

Bone Marrow Diseases

Explore clinical trials studying Bone Marrow Diseases. Study availability and eligibility vary by location and protocol.

3,005 public trials 528 recruiting studies

Refine in advanced search Browse all conditions

Bone Marrow Diseases trial results

Completed

Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes

NCT00331513

Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +39 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Erlotinib Study for Myelodysplastic Syndrome (MDS)

NCT00977548

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

View Trial Details

Completed

Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (H-R MDS)

NCT00882102

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

An Efficacy and Safety Study of Decitabine in Participants With Myelodysplastic Syndrome (MDS)

NCT00744757

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Changhua, Taiwan

Kaohsiung City, Taiwan

Taichung, Taiwan

Tainan, Taiwan

View Trial Details

Completed

Lenalidomide and Decitabine in High Grade Myelodysplastic Syndromes

NCT00828802

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: Duke University Medical Center Durham, North Carolina, United States

View Trial Details

Completed

Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings

NCT01755000

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +17 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Myelofibrosis With Myeloid Metaplasia

NCT00360035

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations: Georgetown University Medical Center Washington D.C., District of Columbia, United States

James A. Haley Veterans Hospital Tampa, Florida, United States

Emory University Atlanta, Georgia, United States

The University of Chicago Chicago, Illinois, United States

View Trial Details

Completed

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS)

NCT00413114

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: Stanford University Stanford, California, United States

Georgetown University Medical Center Washington D.C., District of Columbia, United States

James A. Haley Veterans Hospital Tampa, Florida, United States

Emory University School of Medicine/ Winship Cancer Center Atlanta, Georgia, United States

View all 22 locations

View Trial Details

Completed

Azacitidine in Treating Patients With Chronic Myelomonocytic Leukemia

NCT01235117

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +10 more
Locations: Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom

Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom

View Trial Details

Completed

Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

NCT00454480

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +18 more
Locations: Basingstoke and North Hampshire NHS Foundation Trust Basingstoke, England, United Kingdom

Royal United Hospital Bath, England, United Kingdom

Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust Birmingham, England, United Kingdom

Birmingham Heartlands Hospital Birmingham, England, United Kingdom

View all 96 locations

View Trial Details